C5AR1 and Sepsis: Recently, it was found that blockade of both C5aR and C5L2 abolished adrenomedullary apoptosis in vivo during sepsis, further suggesting that C5aR and C5L2 may be promising targets with implications on future complement-blocking strategies in the clinical setting of sepsis (Flierl et al., 2008a).